Regulation timeline

    Timeline sources

    Milestone dates are shown as recorded in the timeline. Publication, enactment and application dates are distinct. Existing source-check dates are not a new certification; standards may require paid access.

    37 milestones with official documents · 0 without an official document

    37 of 37 milestones

    Glossary sources
    1. · US

      Anti-Kickback Statute enacted

      The Social Security Amendments of 1972 introduced criminal penalties for specified kickbacks, bribes and rebates connected with Medicare and Medicaid services.

      View timeline milestone

      The original law establishes enactment, not every element of today's broader Anti-Kickback Statute.

      No recorded date check

    2. · US

      Medical Device Amendments signed

      Expanded FDA authority over medical devices, established three risk classes and the premarket notification and approval framework.

      View timeline milestone

      Recorded source check:

    3. · US

      IDE regulation scheduled to take effect

      21 CFR Part 812 set the rules for investigational device exemptions, letting unapproved devices be used in clinical studies.

      View timeline milestone

      Printed page 3732 onward. The rule states July 16, 1980 subject to OMB approval; the subsequent approval notice has not been verified.

      No recorded date check

    4. · US

      CLIA '88 signed

      The Clinical Laboratory Improvement Amendments established federal quality standards for laboratories testing human specimens for diagnosis, prevention or treatment; research-only testing is outside that clinical scope.

      View timeline milestone
      • CMS: CLIA '88 signed

        CMS

        https://www.cms.gov/newsroom/fact-sheets/medicare-program-clinical-laboratory-improvement-amendments-clia-1988-fees-cms-3356-nc

      Recorded source check:

    5. · US

      Stark Law enacted

      The Ethics in Patient Referrals Act barred physician self-referral for Medicare-covered services, later expanded in 1993.

      View timeline milestone

      The original prohibition concerned clinical laboratory services. Enactment is distinct from application, and the codified text includes later amendments.

      No recorded date check

    6. · US

      Safe Medical Devices Act signed

      Added device user reporting, postmarket surveillance authority and the Humanitarian Device Exemption.

      View timeline milestone

      Enactment date, not a common application date for all implementing requirements.

      No recorded date check

    7. · US

      HIPAA signed

      The Health Insurance Portability and Accountability Act laid the base for federal privacy and security rules for health data.

      View timeline milestone

      HIPAA enactment, not issuance or compliance dates of the later Privacy and Security Rules.

      • HIPAA, Public Law 104-191

        U.S. government (govinfo.gov)

        https://www.govinfo.gov/content/pkg/PLAW-104publ191/html/PLAW-104publ191.htm

      No recorded date check

    8. · US

      Quality System Regulation takes effect

      21 CFR Part 820 added design controls to device good manufacturing practice requirements.

      View timeline milestone

      Published October 7, 1996, effective June 1, 1997. See Section IV for design-control compliance details.

      No recorded date check

    9. · US

      FDAMA creates De Novo

      The FDA Modernization Act created the De Novo route for novel low to moderate risk devices with no predicate.

      View timeline milestone
      • FDA: FDAMA creates De Novo

        FDA

        https://www.fda.gov/about-fda/fda-history-research-tools/selected-food-drug-cosmetic-device-and-tobacco-laws

      Recorded source check:

    10. · US

      First device user fees (MDUFMA)

      The Medical Device User Fee and Modernization Act introduced user fees tied to FDA review performance goals, renewed every five years.

      View timeline milestone

      Supports original enactment and the fee framework, not subsequent five-year reauthorizations.

      No recorded date check

    11. · International

      IEC 62304 published

      First edition of the software life cycle standard for medical device software.

      View timeline milestone

      Recorded source check:

    12. · US

      HITECH Act signed

      Strengthened HIPAA enforcement and introduced breach notification duties for health data.

      View timeline milestone
      • HHS: HITECH Act signed

        HHS

        https://www.hhs.gov/hipaa/for-professionals/special-topics/hitech-act-enforcement-interim-final-rule/index.html

      Recorded source check:

    13. · US

      Physician Payments Sunshine Act

      Passed within the Affordable Care Act, requiring manufacturers to report payments to physicians and teaching hospitals.

      View timeline milestone

      Enactment within the ACA, not the start of Open Payments reporting or disclosure.

      No recorded date check

    14. · US

      UDI final rule published

      FDA required unique device identifiers on labels and GUDID submissions, phased in by device class.

      View timeline milestone

      Recorded source check:

    15. · US

      NIST Cybersecurity Framework 1.0

      A voluntary framework for managing cybersecurity risk, widely used by manufacturers and hospitals. Version 2.0 followed in February 2024.

      View timeline milestone

      Recorded source check:

    16. · International

      ISO 13485:2016 published

      The current edition of the medical device quality management system standard.

      View timeline milestone

      Recorded source check:

    17. · US

      21st Century Cures Act signed

      Codified the Breakthrough Devices Program and clarified which software functions are not devices.

      View timeline milestone

      Enactment, not the dates of subsequent FDA implementation or guidance.

      No recorded date check

    18. · EU

      MDR and IVDR enter into force

      Regulations (EU) 2017/745 and 2017/746 replaced the device directives, with multi-year transition periods and EUDAMED.

      View timeline milestone

      Recorded source check:

    19. · International

      Health Canada requires MDSAP

      Health Canada's CMDCAS program ended on January 1, 2019 as manufacturers of Class II, III and IV devices sold in Canada transitioned to MDSAP. Existing licence holders had to submit documented transition evidence by December 31, 2018; accepted arrangements allowed some MDSAP audits to take place during 2019.

      View timeline milestone

      Health Canada's transition FAQ, questions 1, 3 and 8, distinguishes the January 1, 2019 program change from the December 31, 2018 evidence deadline. Question 7 exempts distributors, retailers and private-label manufacturers from needing their own MDSAP certificate, while their original equipment manufacturer remains subject to the requirements. This is a Canadian requirement, not a common implementation date for Japan or the other MDSAP countries.

      Recorded source check:

    20. · International

      ISO 14971:2019 published

      Third edition of the risk management standard for medical devices.

      View timeline milestone

      Recorded source check:

    21. · EU

      EU MDR date of application

      The MDR became generally applicable, including Article 117 for drug-device combinations, with separate conditional transition periods for eligible legacy devices.

      View timeline milestone

      Recorded source check:

    22. · International

      IEC 81001-5-1 published

      Security activities for the health software product life cycle, now a key reference for device cybersecurity.

      View timeline milestone

      Recorded source check:

    23. · EU

      EU IVDR date of application

      The IVDR became applicable, with staggered transition deadlines by risk class.

      View timeline milestone

      Recorded source check:

    24. · EU

      MDR transition extended

      Regulation (EU) 2023/607 extended MDR transition periods for legacy devices to 2027 or 2028, depending on class.

      View timeline milestone

      Recorded source check:

    25. · US

      Section 524B cyber requirements apply

      Under FDORA, submissions for cyber devices must include a cybersecurity plan, design controls and an SBOM.

      View timeline milestone

      Recorded source check:

    26. · US

      eSTAR required for 510(k)s

      FDA began requiring 510(k) submissions in the electronic eSTAR format.

      View timeline milestone

      FDA's page identifies October 1, 2023 as the requirement date. The guidance revision is October 2, 2023 and includes waiver and exemption criteria.

      No recorded date check

    27. · EU

      EU AI Act enters into force

      Regulation (EU) 2024/1689 set risk-based rules for AI, with obligations phased in over several years.

      View timeline milestone

      Entry into force is distinct from the phased application of AI Act obligations.

      No recorded date check

    28. · US

      TCET final notice published and effective

      CMS published its final TCET procedural notice, effective the same day, for certain eligible FDA-designated Breakthrough Devices. The pathway was announced on August 7, 2024.

      View timeline milestone
      • CMS final TCET notice

        U.S. government (Federal Register)

        https://www.federalregister.gov/documents/2024/08/12/2024-17603/medicare-program-transitional-coverage-for-emerging-technologies

      • Official GPO copy of the final TCET notice

        U.S. government (govinfo.gov)

        https://www.govinfo.gov/content/pkg/FR-2024-08-12/html/2024-17603.htm

      Recorded source check:

    29. · US

      Initial final PCCP guidance for AI devices

      FDA issued its initial final AI-enabled device PCCP guidance, subsequently updated on August 18, 2025. Guidance recommendations are nonbinding.

      View timeline milestone

      Recorded source check:

    30. · US

      Court vacates FDA LDT rule

      A federal court set aside FDA's rule that would have regulated laboratory-developed tests as devices.

      View timeline milestone

      Recorded source check:

    31. · UK

      UK post-market surveillance rules apply

      MHRA guidance states that strengthened Part 4A PMS requirements apply to individual medical devices placed on the market or put into service in Great Britain from June 16, 2025, regardless of CE or UKCA marking. Earlier individual devices remain under prior PMS rules. Custom-made devices have a reduced set of obligations; Northern Ireland follows EU MDR and IVDR PMS requirements.

      View timeline milestone

      MHRA explicitly states June 16, 2025. SI 2024/1368 was made December 16, 2024 and regulation 1(2) says it comes into force 6 months after the day it was made; the consolidated Part 4A annotation instead records June 17, 2025. The displayed date follows MHRA's operational guidance, not a resolution of this official one-day discrepancy. The guidance also excludes specified Secretary of State authorisations from these requirements and refers in-house manufacture to separate guidance.

      Recorded source check:

    32. · US

      FDA updates AI device PCCP guidance

      FDA issued updated final recommendations for predetermined change control plans for AI-enabled device software functions, replacing the December 4, 2024 version. This is guidance issuance, not a new statutory effective date.

      View timeline milestone

      Recorded source check:

    33. · US

      FDA implements LDT rule vacatur

      FDA published a final rule, effective the same day, restoring the pre-May 2024 wording of 21 CFR 809.3(a) following the March 31, 2025 court vacatur.

      View timeline milestone

      Recorded source check:

    34. · US

      QMSR takes effect

      FDA's Quality Management System Regulation replaced the QSR, incorporating ISO 13485:2016 by reference.

      View timeline milestone
      • FDA: QMSR takes effect

        FDA

        https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-management-system-regulation-qmsr

      Recorded source check:

    35. · EU

      First four EUDAMED modules become mandatory

      Actor, UDI/Device, Notified Bodies & Certificates and Market Surveillance modules became mandatory, with applicable transition provisions. Market Surveillance is for competent authorities and the Commission; the remaining modules are not yet mandatory.

      View timeline milestone

      Recorded source check:

    36. · International

      Australian UDI first phase begins

      UDI labelling and AusUDID data requirements began for in-scope Class IIb and III devices, subject to exclusions and transition arrangements. Other classes are phased in later.

      View timeline milestone
      • TGA UDI commencement

        TGA

        https://www.tga.gov.au/news/news-articles/new-udi-requirements-medical-devices-commence-1-july-2026

      Recorded source check:

    37. · EU

      AI Act high-risk rules for devices

      Regulation (EU) 2026/1744 amended the AI Act timetable: Article 6(1) high-risk systems tied to Annex I products, including qualifying MDR/IVDR devices requiring third-party assessment, apply from August 2, 2028, rather than the original August 2, 2027 date.

      View timeline milestone

      The amended August 2, 2028 deadline has not been independently verified against the operative amendment to Article 113. EUR-Lex returned no readable text during this audit; the recorded source-check date is not verification.

      Recorded source check:

    Linked documents are evidence for review, not certification of every milestone claim.